Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Rose, Héloïse Lucaccioni, Kimberly Marsh et al.|Eurosurveillance|2025Cited by 24
An Early Stage Researcher's Primer on Systems Medicine TerminologyMassimiliano Zanin, Hui Wang, Nadim A.A. Aitya et al.|Network and Systems Medicine|2021Cited by 15
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Héloïse Lucaccioni, the European IVE group, Diogo F.P. Marques et al.|Eurosurveillance|2026Cited by 7
Influenza Vaccine Effectiveness During the 2023/2024 Season: A Test‐Negative Case–Control Study Among Emergency Hospital Admissions With Respiratory Conditions in Northern IrelandMagda Bucholc, Declan Bradley, Mark G. O’Doherty|Influenza and Other Respiratory Viruses|2025Cited by 3
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020–2021Michelle K. Greene, Christopher J. Scott, Kevan Duffin et al.|Heliyon|2024Cited by 1